tiprankstipranks
Trending News
More News >
Haemonetics Corp. (HAE)
NYSE:HAE
US Market

Haemonetics (HAE) Income Statement

Compare
430 Followers

Haemonetics Income Statement

Last quarter (Q2 2026), Haemonetics's total revenue was $327.31M, a decrease of -5.27% from the same quarter last year. In Q2, Haemonetics's net income was $38.68M. See Haemonetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.36B$ 1.31B$ 1.17B$ 993.20M$ 870.46M
Gross Profit
$ 778.55M$ 711.91M$ 622.87M$ 530.77M$ 428.45M
Operating Expenses
$ 556.73M$ 547.03M$ 466.84M$ 450.02M$ 338.70M
Depreciation and Amortization
$ 108.89M$ 88.61M$ 84.81M$ 86.55M$ 84.29M
EBITDA
$ 355.99M$ 295.45M$ 252.01M$ 191.72M$ 184.38M
Operating Income
$ 221.82M$ 164.88M$ 156.03M$ 80.75M$ 89.75M
Other Income/Expenses
$ -9.75M$ -13.02M$ -14.63M$ -17.12M$ -16.83M
Pretax Income
$ 212.07M$ 151.87M$ 141.40M$ 63.63M$ 72.91M
Net Income
$ 167.68M$ 117.56M$ 115.40M$ 43.38M$ 79.47M
Per Share Metrics
Basic EPS
$ 3.31$ 2.32$ 2.27$ 0.85$ 1.57
Diluted EPS
$ 3.31$ 2.29$ 2.24$ 0.84$ 1.55
Weighted Average Shares Outstanding
50.33M 50.71M 50.78M 51.05M 50.69M
Weighted Average Shares Outstanding (Diluted)
50.73M 51.40M 51.42M 51.35M 51.29M
Currency in USD

Haemonetics Earnings and Revenue History